BUZZ-Australia's biotech firm Biotron rises on Sedarex acquisition

Reuters10-15

** Shares of Biotron BIT.AX rise as much as 42.9% to A$0.005, hitting their highest level since August 14

** Stock logs its highest intraday pct gain since August 13

** The biotech firm acquires Sedarex, an unlisted company which holds global patents for SedRx - a next-gen general anaesthetic

** Co says deal for A$1.5 million ($9,75,750.00), among others

** Under deal, co raising A$1 million through placement at issue price of A$0.003 apiece

** Stock down 68.3% this year, including the day's move

($1 = 1.5373 Australian dollars)

(Reporting by Rajasik Mukherjee in Bengaluru)

((Rajasik.Mukherjee@thomsonreuters.com))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2575727846?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-10-15 10:23","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2575727846","market":"nz","top_or_hot":-1,"title":"BUZZ-Australia's biotech firm Biotron rises on Sedarex acquisition","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BUZZ-Australia's biotech firm Biotron rises on Sedarex acquisition</title></head><body><p>** Shares of Biotron <span>BIT.AX</span> rise as much as 42.9% to A$0.005, hitting their highest level since August 14</p><p>** Stock logs its highest intraday pct gain since August 13</p><p>** The biotech firm acquires Sedarex, an unlisted company which holds global patents for SedRx - a next-gen general anaesthetic </p><p>** Co says deal for A$1.5 million ($9,75,750.00), among others</p><p>** Under deal, co raising A$1 million through placement at issue price of A$0.003 apiece</p><p>** Stock down 68.3% this year, including the day's move</p><p>($1 = 1.5373 Australian dollars)</p><p> (Reporting by Rajasik Mukherjee in Bengaluru)</p><p> ((Rajasik.Mukherjee@thomsonreuters.com))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BUZZ-Australia's biotech firm Biotron rises on Sedarex acquisition</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBUZZ-Australia's biotech firm Biotron rises on Sedarex acquisition\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-10-15 10:23</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BUZZ-Australia's biotech firm Biotron rises on Sedarex acquisition</title></head><body><p>** Shares of Biotron <span>BIT.AX</span> rise as much as 42.9% to A$0.005, hitting their highest level since August 14</p><p>** Stock logs its highest intraday pct gain since August 13</p><p>** The biotech firm acquires Sedarex, an unlisted company which holds global patents for SedRx - a next-gen general anaesthetic </p><p>** Co says deal for A$1.5 million ($9,75,750.00), among others</p><p>** Under deal, co raising A$1 million through placement at issue price of A$0.003 apiece</p><p>** Stock down 68.3% this year, including the day's move</p><p>($1 = 1.5373 Australian dollars)</p><p> (Reporting by Rajasik Mukherjee in Bengaluru)</p><p> ((Rajasik.Mukherjee@thomsonreuters.com))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK7501","symbol_name":"新冠治疗股","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251015:nL6N3VW04Q:1","article_id":"2575727846","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2575727846","pubTimestamp":1760495022,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"BUZZ-Australia's biotech firm Biotron rises on Sedarex acquisition** Shares of Biotron BIT.AX rise as much as 42.9% to A$0.005, hitting their highest level since August 14** Stock logs its highest intraday pct gain since August 13** The biotech firm acquires Sedarex, an unlisted company which holds global patents for SedRx - a next-gen general anaesthetic ** Co says deal for A$1.5 million , among others** Under deal, co raising A$1 million through placement at issue price of A$0.003 apiece** Stock down 68.3% this year, including the day's move  ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK7501":"新冠治疗股","BK7067":"生物科技","BK7508":"医药生物股","BIT.AU":"BIOTRON LIMITED"},"translate_title":"BUZZ-澳大利亚生物技术公司Biotron因收购Sedarex而崛起","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"BIT.AU":0.9},"content_text":"BUZZ-Australia's biotech firm Biotron rises on Sedarex acquisition** Shares of Biotron BIT.AX rise as much as 42.9% to A$0.005, hitting their highest level since August 14** Stock logs its highest intraday pct gain since August 13** The biotech firm acquires Sedarex, an unlisted company which holds global patents for SedRx - a next-gen general anaesthetic ** Co says deal for A$1.5 million ($9,75,750.00), among others** Under deal, co raising A$1 million through placement at issue price of A$0.003 apiece** Stock down 68.3% this year, including the day's move($1 = 1.5373 Australian dollars) (Reporting by Rajasik Mukherjee in Bengaluru) ((Rajasik.Mukherjee@thomsonreuters.com))","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding,corporation,merge","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2575727846","isCrawlerRequest":true}